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Abstract
It is uncertain whether multiple micronutrients benefit the mental and psychomotor development of young children in developing
countries. We conducted a randomised double-blind controlled trial to evaluate the effect of a richly micronutrient-fortified v. a basal for-
tified porridge on mental and psychomotor development in Zambian infants. Infants (n 743) were randomised at age 6 months to receive
either the richly fortified or the basal fortified infant food and were followed up until 18 months of age. All the infants were evaluated
monthly for achievement of a series of developmental milestones. The Bayley scales of infant development II were administered to a sub-
sample of 502 infants at 6, 12 and 18 months. Rich micronutrient fortification had no significant benefit on the following: (a) number of
developmental milestones achieved (rate ratio at 12 months ¼ 1·00; 95 % CI 0·96, 1·05; P¼0·81, adjusted for sex, socio-economic status and
maternal education, with similar results at 15 and 18 months); (b) ages of walking unsupported (hazard ratio (HR) 1·04; 95 % CI 0·88, 1·24;
P¼0·63, adjusted for the above covariates) and of speaking three or four clear words (HR 1·01; 95 % CI 0·84, 1·20; P¼0·94, adjusted for the
above covariates); (c) mental development index (MDI) and psychomotor development index (PDI) of the Bayley scales (scores difference
adjusted for baseline scores, age at the assessment, sex, socio-economic status, maternal education, language, age and HIV status: MDI 0·3
(95 % CI 20·5, 1·1), P¼0·43; PDI 20·1 (95 % CI 20·9, 0·7), P¼0·78). In conclusion, the results do not support the hypothesis that rich
micronutrient fortification improves Zambian infants’ mental and motor development.
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Developmental milestones
In many developing countries, Fe and iodine deficiencies have
a detrimental effect on early childhood development(1). Poor
levels of cognitive function on entering school are associated
with reduced educational attainment that may subsequently
affect productivity in adult life(2). Many other micronutrients
are deficient in developing countries including vitamins A,
B12, D, E, riboflavin and Zn
(3), and nutrition programmes
have started to use multiple micronutrients. However, the
benefit to child development of multiple micronutrients is
not clear.
In a recent systematic review and meta-analysis, multiple
micronutrient supplementation was associated with small
increases in certain cognitive functions in school children(4).
In children younger than 5 years, only a few studies have
investigated the effect of multiple micronutrient interventions,
with conflicting results: four trials in Ghana(5), Bangladesh(6),
South Africa(7) and Zanzibar(8) found better motor develop-
ment in the arms receiving multiple micronutrients, two
trials in Nepal(9) and India(10) did not find any effect of mul-
tiple micronutrient supplementation on motor development
and on both mental and motor development, respectively.
One trial in Indonesia found worse mental development per-
formance in an 18-month-old cohort but no effect in 12 month
olds compared with control infants(11).
Micronutrient deficiencies are common in Zambia and
micronutrient-rich foods are often expensive and unafford-
able(12,13). Programmes of universal fortification of sugar
with vitamin A and salt with iodine have been established(12).
*Corresponding author: Dr Daniela Manno, fax þ44 20 7958 811, email daniela.manno@lshtm.ac.uk
Abbreviations: BSID, Bayley scales of infant development; CIGNIS, Chilenje Infant Growth, Nutrition and Infection Study; MDI, mental development index;
PDI, psychomotor development index; SES, socio-economic status.
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However, the first 2 years of life are a period of rapid growth
and development and available complementary foods may
not meet the children’s needs(14). Specialised interventions
are needed to increase the quality of complementary foods
in this group.
We have conducted a randomised double-blind controlled
trial of the efficacy of two locally produced complementary/
replacement foods, fortified with different levels of micronutri-
ents, for infants aged 6 to 18 months. The primary outcome
was the prevalence of stunting at 18 months and the results
were recently published(15). The rich micronutrient fortifica-
tion did not reduce stunting but did improve Fe status and
reduce anaemia(15). The present paper describes the second-
ary outcome of mental and motor development assessed on
developmental milestones and the Bayley scales at 12 and
18 months.
Materials and methods
Study design
The Chilenje Infant Growth, Nutrition and Infection Study
(CIGNIS) was a randomised double-blind controlled clinical
trial. The study is registered as ISRCTN37460449 (http://
www.controlled-trials.com/mrct). Children were randomised
to one of two locally produced porridges at age 6 months,
and were followed monthly for 12 months.
Study population and recruitment
The trial was conducted in Chilenje, Lusaka, Zambia, from
October 2005 to July 2009. Infants were recruited by
approaching mothers attending the child health section of
the government clinic on the same site as the project clinic.
As over 90 % of Lusaka women take their infants to the
clinic for monthly weighing and standard vaccinations(16),
the population approached for participation in the study
was representative of the area. Infants were eligible if they
were aged 6 months (^2 weeks), in generally good health
and their mothers gave written consent to attend monthly
clinic visits for the next year, feed their infants the allocated
porridge and have their infant undergo project tests. Know-
ledge of maternal HIV status was not a requirement for joining
the study but 90 % of women knew their status from antenatal
HIV antibody testing in the government health service.
Randomisation
Individual randomisation was in blocks of twenty; the code
was held by the project Data Safety and Monitoring Board.
Each 1 kg bag of porridge flour was labelled with the partici-
pant identifier (ID) number. At the recommendation of the
Data Safety and Monitoring Board, an independent observer
audited the randomisation and labelling process halfway
through the study and found it to be robust, accurate and
able to maintain blinding of other study staff and participants.
Infants were allocated to porridges by sequential numbers on
recruitment. There was one protocol violation: during May
and June 2007, one porridge ran out but staff continued
to recruit to the other porridge group; sixty-eight children
were thus not appropriately randomised. For ethical reasons,
they were followed in the study but are not included in the
present analyses.
Intervention
The two porridges, based on local products, were similar in
bulk ingredients and macronutrient content but differed in
micronutrient content (Table 1). In pilot work, they were
found to be acceptable(17) by the local population and to dis-
place other micronutrient-poor complementary or family
foods but not to displace breast milk intake(18). The energy
density of the porridge prepared according to package direc-
tions (equivalent to 30 g blended in 250 ml water) was 3·18 kJ
(0·76 kcal)/g(18); protein represented 16 % of energy. The
richly fortified porridge contained micronutrients to meet
the WHO estimated needs for infants aged 9–11 months
with low breast milk intake, assuming an intake of 50 g
flour/d(19). The basal porridge had micronutrients at levels
that would be in the maize component if national maize
fortification which was planned when we started the study
were introduced(12,20), which has not occurred. Micronutrient
premixes for both flours were prepared by DSM (Isando,
South Africa).
Table 1. Composition of trial porridge flours
Basal fortification
(per kg flour)*
Rich fortification
(per kg flour)†
Maize (g) 650 615
Groundnuts (g) 150 150
Bambaranuts (g) 50 50
Beans (white and yellow) (g) 150 150
Vitamin A (mg) 0·65 6·5
Vitamin C (g) – 2·0
Vitamin D (mg) – 0·1
Thiamin (mononitrate) (mg) 1·3 9
Riboflavin (mg) 1·6 11·2
Niacin (niacinamide) (mg) 13 140
Pyridoxine (HCl) (mg) 1·6 8·6
Folate (mg) 0·65 2·21
Vitamin B12 (mg) 3·25 9·75
Pantothenic acid (mg) – 40·3
Mg (oxide) (g) – 0·94
Fe (ferrous fumarate)‡ (mg) 6·5 250
Zn (oxide)‡ (mg) 9·75 200
Cu (gluconate) (mg) – 3·2
Mn (sulfate monohydrate) (mg) – 12·0
Se (sodium selenite) (mg) – 0·2
Ca (CaH(PO4).2H2O)‡ (g) – 6·8
P (CaH(PO4).2H2O) (g) – 5·3
* Based on estimated amounts of micronutrients that would be available from 50 g
porridge flour/d made with maize fortified at levels planned nationally for Zambia.
Overages (usually 10 %) added to allow for losses during processing.
† Based on total estimated micronutrient needs of infants aged 9–11 months minus
amounts expected from low breast milk intakes(19) and assuming intake of 50 g
porridge flour/d. Exceptions to the micronutrient levels are that vitamin C was
increased to compensate for low Fe bioavailability and Zn was based on the rec-
ommended daily allowance set by the International Zinc Consultative Group in
2004(38). Overages (usually 10 %) added to allow for losses during processing.
‡ Phytate was analysed in two batches of each flour and averaged 5·8 g/kg. This
translated into phytate:Zn molar ratios of about 19 in the basal flour and about
3·3 in the richly fortified flour and phytate:Fe molar ratios of 5·6 and 1·7 in the
two flours, respectively.
Micronutrients and infant development 557
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
Adherence
Women were given 4 kg of porridge flour each month and
could return for more as required. They were instructed to
prepare the porridge according to the directions on the pack-
age, using a plastic cup, graduated in ml, supplied by the
investigators. Adherence was determined through monthly
questioning of mothers as to how much prepared porridge
the child had consumed (in ml) within each of the 2 d
before the visit and whether consumption on these days was
typical. For each month the mean and standard deviation
reported intake of the porridge food provided was calculated
for ‘typical’ days. Infants were given adherence scores of 1
(low, ,1 SD below the mean), 2 (average, ^1 SD of the
mean) or 3 (high, .1 SD above the mean). Missed visits
were assigned an adherence value of 1.
Measurements
At recruitment, sociodemographic information was obtained
by questionnaire. Infants had their developmental milestones
assessed at the monthly visits to the clinic. Bayley scales of
infant development (BSID), anthropometric measurements
and Hb concentration were evaluated at 6, 12 and 18
months of age at the clinic. At 18 months, children were
tested for antibodies to HIV using Determine HIV 1/2 (Inver-
ness Medical, Tokyo, Japan) and the results confirmed using
Unigold HIV 1/2 (Trinity Biotech plc, Bray, Co. Wicklow,
Republic of Ireland).
Development milestones. Data on the attainment of mile-
stones were collected using a test previously developed for
Bangladeshi children that included motor milestones taken
from the WHO Multicentre Growth Reference Study(21).
Mothers were asked at each monthly visit whether and at
what age their child had achieved any of the following devel-
opmental milestones: (1) motor skills: hands come together,
picks up small objects, transfers spoon from hand to hand,
sits unsupported, sits supported, crawls, standing with sup-
port, standing unsupported, walks supported, walks unsup-
ported; (2) language skills: babbles, says three or four clear
words; and (3) social development: smiles when smiled at,
shows apprehension at strangers. Children were asked to
demonstrate any new milestone reported by the mothers.
The milestone was recorded as achieved only after project
staff witnessed it.
Mental and psychomotor development evaluation. BSID
II were used to assess child development. The test has two
subscales: the mental development index (MDI) and psycho-
motor development index (PDI) and was standardised in the
USA(22). Each index is age-normalised with respect to a popu-
lation mean of 100 and SD of 15. The test was administered by
two trained psychologists (P. K. K. and H. K. B.). A few of the
items were adapted to the different setting (for example,
appearance of the dolls or pictures of the houses) but the
underlying constructs were unchanged. The test was trans-
lated to and back-translated from the local languages
(Bemba and Nianja) and administered in the language that
was spoken most in the household. If a child was sick on
the day of the assessment, the mother was asked to bring
the child back 1–2 weeks after recovery.
Data management and statistical methods
Data were double-entered and verified in Access (Microsoft
Corp, Redmond, WA, USA). Range and logical checks were
run in Access and in Stata (StataCorp LP, College Station, TX,
USA). Stata version 11 was used for all analyses. The analysis
plan was finalised before the trial was unblinded.
Numbers of infants missing development evaluations were
reported by trial arm. Characteristics of missing infants were
examined by logistic regression to verify if there were impor-
tant differences between infants with complete and incom-
plete data and to investigate the most plausible missing data
mechanism(23).
The number of milestones reached at 12, 15 and 18 months
was compared between trial arms using Poisson regression(24).
We chose 12- and 18-month time points because the Bayley
test was performed at these visits. However, since early results
indicated that . 90 % of children had reached most of the
milestones at 18 months, we included also an evaluation at
15 months. The mean age of walking unsupported and speak-
ing three or four clear words were compared between trial
arms using Cox regression(24).
Inter-observer reliability of the Bayley test was obtained in
663 testing sessions in which the same child was scored by
the two psychologists. The intra-class correlation coefficient
(ICC) of inter-rater data was calculated using one-way
ANOVA. A good agreement between assessors was found for
both MDI (ICC ¼ 0·91; 95 % CI 0·89, 0·92) and PDI
(ICC ¼ 0·91; 95 % CI 0·90, 0·92). Associations of Bayley test
scores at 6 and 18 months with characteristics of the partici-
pants and their socio-economic background were examined
by linear regression. At 18 months, the analysis was adjusted
for treatment arm.
MDI and PDI scores were analysed as continuous variables
and checked for normality by normal probability plot. The
comparison of MDI and PDI scores at 12 and 18 months
between trial arms was made with multivariable linear
regression with subsequent adjustment for baseline scores,
imbalances at baseline and possible confounding factors.
A two-sided P#0·05 was considered statistically significant.
Maternal education, language spoken and socio-economic
status (SES) were considered a priori confounders and were
adjusted for in the analyses. SES was measured using an
asset index, created by combining data on possessions and
housing characteristics using principal component analysis(25).
Stunting was considered as length/age Z score , 22, calcu-
lated using the WHO growth reference data(26) and the
child’s exact age at measurement. Anaemia was defined as
Hb level , 105 g/l. Although Bayley MDI and PDI scores
were already age standardised, we included age at the assess-
ment in the multivariate model because their standardisation
is based on data from the USA and it may not be sufficient
to control for the confounding effect of age in this population.
To explore the effects of trial intervention on MDI and
PDI scores over the entire follow-up period, alternative
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mixed-effects linear regression models were fitted(27).
A random-intercept and random-slope model was found to
best account for the between-child variation in the trajec-
tories. Baseline scores, imbalances at baseline and a priori
confounding factors were also included. In addition, since
a random-effect model leads to unbiased estimates even in
the presence of missing values in the outcome variables
(i.e. infants lost to follow up or missing the intermediate
visit) under the missing at random assumption, we included
in the model the covariates that were found to be associa-
ted with missingness(23). Time–treatment interaction and
interactions between treatment and sex, maternal HIV,
breast-feeding and anaemia at baseline were explored as
programmed in the analysis plan.
Sample size
The sample size calculations were done considering the pri-
mary outcome – stunting – of the trial(15). Developmental
milestones were collected in all the infants in the CIGNIS trial.
For the Bayley test, we hypothesised a treatment effect of
0·3 SD or five points on the MDI and PDI, based on previous
studies of the effect of nutritional supplementation on mental
and motor development(28). Because the full sample size of
the trial was not needed to detect this difference with 90 %
power and 5 % level of significance, only a subsample of chil-
dren was assessed with the Bayley scales. Bayley testing was
done in a subsample (n 502) that included all the children
of HIV-positive or HIV-unknown mothers and every other
child of HIV-negative women. In addition, this subsample
received an intestinal permeability test, another secondary
objective of the trial that is not reported here.
Ethics
The study was conducted according to the Declaration of
Helsinki and Good Clinical Practice. The ethics committees
of the University of Zambia and the London School of Hygiene
and Tropical Medicine approved it. Mothers gave written
informed consent. Neither funding source (the Bill and
Melinda Gates Foundation and DSM South Africa) was
involved in conduct, analysis or interpretation of the study.
Results
Developmental milestones
Developmental milestones were recorded for 740 children
of the 743 participating in the CIGNIS study (data were
not collected for three infants who left the study after a
few weeks).
As already described in the analysis of the main trial out-
come(15), there was a 23 % loss to follow-up in both trial
arms before the infants reached 18 months (Supplemental
Fig. 1; available online at http://www.journals.cambridge.
org/bjn). There were more infants of HIV-uninfected women
(77 %) among those lost to follow-up than among those who
completed the study (68 %) but these groups were otherwise
similar(15).
The amount of porridge consumed increased with age from
about 268 ml/d (about 32 g flour/d) at 7 months to about
369 ml/d (about 44 g flour/d) from 11 to 18 months. There
was no evidence that adherence differed between treatment
groups (OR and 95 % CI for proportion of visits with high
adherence in the richly fortified compared with the basal
diet: OR 0·79; 95 % CI 0·61, 1·04).
At baseline, the trial arms were substantially balanced
(Supplemental Table 1; available online at http://www.
journals.cambridge.org/bjn)(15) and not different in terms
of number of milestones reached (Table 2). At 12, 15 and
18 months the number of milestones attained did not differ
between trial arms. As expected, none of the children was
able to walk unsupported or speak three or four clear words
at 6 months. Age of achieving the two above milestones was
similar between trial arms (Fig. 1). These results did not
change after adjusting for the sex of the child and education
and SES of the mother. There was no evidence of interactions
between treatment and child’s sex, anaemia at baseline,
breast-feeding and maternal HIV status (data not shown).
Bayley test
Among the 743 infants enrolled in the CIGNIS trial and
randomised, a subsample of 502 was assigned to Bayley
testing according to the study design; of those, 256 (51 %)
were in the basal fortified porridge group and 246 (49 %) in
the richly fortified porridge group (Fig. 2).
Table 2. Developmental milestones achieved by four consecutive time points by trial arm
(Medians and interquartile ranges (IQR) and rate ratios (RR) and 95 % confidence intervals)
No. of milestones achieved
Basal fortified
porridge (n 370)
Richly fortified
porridge (n 370) Unadjusted* Adjusted†
Age n Median IQR Median IQR RR 95 % CI P RR 95 % CI P
6 months 740 8 7–9 8 7–9 1·00 0·95, 1·06 0·90 – – –
12 months 619 13 12–13 13 12–13 1·00 0·96, 1·05 0·91 1·00 0·96, 1·05 0·88
15 months 583 14 13–14 14 13–14 1·00 0·96, 1·05 0·76 1·00 0·96, 1·05 0·77
18 months 576 14 14–14 14 14–14 1·00 0·96, 1·05 0·92 1·00 0·96, 1·05 0·93
* Basal fortified porridge used as the baseline category.
† Adjusted for sex, socio-economic status and maternal education.
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As planned, all the infants of HIV-positive/unknown
mothers and approximately half of the infants of HIV-negative
mothers were included in the Bayley test subsample (Table 3,
left-hand columns). Baseline characteristics did not differ
between infants of HIV-negative mothers assigned and not
assigned to Bayley testing.
Trial arms were reasonably balanced at baseline (Table 3,
right-hand columns), although there was some evidence of
an excess of girls (P,0·04) and more mothers with none/
primary education (P,0·02) in the richly fortified arm. At
18 months, 332 of the 335 infants followed up were tested
for HIV antibodies and thirteen (4 %) were HIV positive.
Bayley test assessment was affected by missing data at
baseline and at follow up. Their frequency and consequences
are discussed below.
Loss at baseline: thirty-nine infants in the richly fortified
porridge group and forty-three in the basal fortified group,
who were assigned to Bayley testing according to the study
design, were not assessed at baseline (Fig. 2). The main
reason was the mother’s refusal to spend the time to receive
the full protocol including the Bayley test and gut permeability
test. A total of five infants did not receive the full protocol
because trial staff incorrectly gave them the reduced protocol.
An incorrect HIV status was reported by four mothers, which
was subsequently ascertained by checking clinical charts; this
influenced the assignment of their infants to the full protocol.
Also, ten infants did not receive the Bayley test because the
solution for gut permeability was not available and they
were assigned to the reduced protocol. As a result, among
those 502 planned to receive Bayley testing, only 420 (84 %)
were assessed at baseline (Fig. 2). The infants who missed
Bayley assessment did not substantially differ from those
who received Bayley testing in baseline characteristics,
growth and developmental milestones achieved (data not
shown) except that the proportion of HIV-negative mothers
was significantly higher in the group missing the Bayley test
(94 v. 48 %; P,0·01).
Loss to follow-up: among 420 infants assessed at baseline
with the Bayley test, eighty-five (20 %) were lost between
6 and 18 months, with no evidence of a difference between
treatment arms (18 % in basal and 23 % in micronutrient-
fortified arm; P¼0·22). Baseline characteristics were similar
between these infants and those who completed the study
(data not shown), except that mothers lost to follow up
were younger (mean age 24·7 (SD 6·0) v. 27·2 (SD 5·9) years;
P,0·01), and the proportion that was HIV negative was
slightly higher (54 v. 46 %; P¼0·07). MDI and PDI scores at
baseline and before withdrawal were not significantly differ-
ent in those lost to follow up compared with children who
completed (data not shown).
The available Bayley testing measures obtained on these
children were first studied in relation to the children and
their mothers’ baseline characteristics, and then in relation to
the assigned intervention as follows.
At baseline, both MDI and PDI were significantly associated
(P,0·01) with birth weight and concurrent stunting (Table 4).
Infants who were anaemic had on average lower MDI and
PDI scores compared with non-anaemic ones, but the differ-
ence was statistically significant (P¼0·01) only for MDI. At
18 months, there was still evidence of an association of both
MDI and PDI scores with concurrent stunting (P,0·01).
Infants born with low birth weight had lower scores also at
18 months, but the difference was statistically significant
only for PDI (P,0·01). PDI was also associated with maternal
education, SES and language. In infants of HIV-positive
mothers, there was some evidence of poorer MDI and PDI
scores at 18 months compared with infants of HIV-negative
or HIV-unknown mothers (P¼0·03). MDI and PDI scores
were lower in those thirteen infants who were found to be
HIV infected at 18 months, but the difference was not statisti-
cally significant.
Both MDI and PDI decreased from 6 to 18 months similarly
in both treatment arms (Table 5). Significant differences
between treatment arms were seen only for PDI at 18
months (P¼0·03); infants in the richly fortified arm scored
on average 1·6 points lower than those in the basal fortified
arm (Table 5). This result did not substantially change after
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Fig. 1. Age of speaking three or four clear words (a) and of walking unsup-
ported (b) by intervention arm. Probabilities of reaching the milestones were
estimated using Kaplan–Meier methods. The hazard ratios (HR) of reaching
the milestones for the richly fortified porridge arm (—) compared with the
basal fortified porridge arm (·····) are presented as crude HR and adjusted by
sex, socio-economic status and maternal education. Age of speaking three
or four clear words: crude HR 1·02 (95 % CI 0·85, 1·21), P¼0·84; adjusted
HR 1·01 (95 % CI 0·84, 1·20), P¼0·94. Age of walking unsupported: crude
HR 1·06 (95 % CI 0·89, 1·26), P¼0·49; adjusted HR 1·04 (95 % CI 0·88,
1·24), P¼0·63.
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adjusting for baseline scores, imbalances at baseline between
trial arms (sex and maternal education) and a priori con-
founding factors (age at the assessment, maternal language
and SES). However, these results could be affected by losses
to follow up.
Results from the mixed-effects linear regression models
showed that, after adjusting for baseline scores, imbalances
at baseline, a priori confounding factors and characteristics
associated with missingness (mother’s age and HIV status),
there was no evidence that the children in the richly fortified
porridge arm had, considering the overall study period, differ-
ent MDI and PDI scores compared with the basal fortified
porridge arm (difference in MDI scores: 0·3 (95 % CI 20·5,
1·1), P¼0·43; difference in PDI scores: 20·1 (95 % CI 20·9,
0·7), P¼0·78). There was no evidence of interactions between
treatment and follow-up time, infant’s sex and anaemia at base-
line, maternal HIV status and breast-feeding (data not shown).
Discussion
In the CIGNIS trial, provision from ages 6 to 18 months of
a micronutrient-richly fortified porridge, formulated to
meet all nutritional requirements according to current best
estimates(19), did not show any clear benefit on mental and
psychomotor development evaluated with developmental
milestones and BSID II. There was evidence from mothers’
report that the children took the supplement and there was
a good response in Hb levels(15). The only significant differ-
ence seen was that PDI scores at 18 months were lower in
the richly fortified porridge arm compared with the control
arm, which is the opposite to our hypothesis that multiple
micronutrients would benefit child development. However,
the difference was very small (1·6 points) and was below
that one generally considered clinically relevant(28). Moreover,
the longitudinal analysis, which corrects for incomplete infor-
mation due to missing data, indicated no evidence of an
intervention effect on MDI or PDI on the overall study period.
The infants’ Bayley scores were in the normal range at
baseline but decreased with age, while achievement of
motor and language milestones reflected the standards for
healthy children up to 15 months of age(29,30). Most children
attained all milestones before 18 months, so no milestone
was available to measure developmental level in the older
age range. The decline in Bayley scores with age in these
Zambian children is consistent with findings in other
resource-poor settings(6,10,11,31–34). The decrease could be
attributed to cumulative developmental delay due to dis-
advantaged backgrounds compared with US standards.
811 infants enrolled in the trial
743 randomised
502 assigned to Bayley testing
256 in basal fortified porridge group
213 assessed at 6 months 207 assessed at 6 months
39 not assessed at baseline
(30 mothers refused, 2 by
mistake, 6 solution for the
gut permeability test not
available, 1 mother gave
incorrect HIV status)
27 lost to follow up
(15 withdrew from the
trial, 9 moved out of
the study area, 3 died)
23 lost to follow up
(14 withdrew from the trial,
6 moved out of the study area,
3 died)
2 could not
come for the
visit
4 could not
come for the
visit
178 assessed at 12 months
160 assessed at 18 months175 assessed at 18 months
15 lost to follow up
(9 withdrew from the trial,
4 moved out of the study
area, 2 sick at the time of
testing)
186 assessed at 12 months
20 lost to follow up
(10 withdrew from the trial,
6 moved out of the study
area, 2 died, 2 sick at the
time of testing)
43 not assessed at baseline
(32 mother refused, 3 by
mistake, 4 solution for the gut
permeability test not available,
3 mother reported incorrect
HIV status, 1 infant died)
246 in richly fortified porridge group
241 not assigned to Bayley testing
according to the design of the study
68 inadequately randomised
Fig. 2. Flow diagram displaying infants recruited in the Bayley test subsample and lost to follow up by treatment arm.
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Although some of the families were classified as middle/high
class, approximately 23 % of children were stunted by the
end of the study and about one-third of the mothers had pri-
mary education only. Unfortunately, we had no measure of
stimulation in the home, an important determinant of child
development. Zambian infants had lower variability of
scores compared with the reference US population(35). This
is probably explained by the fact that the US reference popu-
lation included a representative sample of all socio-economic
and ethnic groups and geographical regions, whereas the
CIGNIS infants were from one urban area and were ethnically,
socio-economically and culturally more homogeneous.
There are no standardised infant tests available for Zambia.
However, one or both Bayley scores at baseline were related
to low birth weight, stunting and anaemia in the expected
direction(2,36). Furthermore, at 18 months when the effect of
environment is generally more apparent, the Bayley scores
were also related to mothers’ HIV status and educational
level, the language spoken at home and SES, all in the
expected direction. Inter-observer reliability was good, so
the scores appear to be valid for Zambian children. Further-
more, the Bayley scales have been used to assess infant devel-
opment in many studies in low- and middle-income
countries(6,10,31–34). Since the study began, a new tool to
assess child development milestones in rural African settings
has been developed and validated in Malawian children(37).
A posteriori comparison is difficult because the test was
designed specifically for a rural environment, while our infants
are from an urban setting. However, age of walking unsup-
ported and speaking three or four clear words in our infants
are compatible with the normal range in those Malawian
infants(37).
Table 3. Baseline characteristics of children assigned (n 502) and not assigned (n 241) to Bayley testing, and of those assigned to Bayley testing by
intervention arm
(Numbers in groups and percentages or mean values and standard deviations)
Children assigned (n 502) and not assigned (n 241) to Bayley testing
by HIV status
Children assigned to Bayley testing
by intervention arm
Mother HIV
positive (n 157) or
unknown (n 67)*
Mother HIV negative
assigned (n 278)
Mother HIV
negative not
assigned (n 241)
Basal fortified
porridge (n 256)
Richly fortified
porridge (n 246)
n % n % n % n % n %
Infants’ characteristics
Age (months)
Mean 6·1 6·1 6·0 6·1 6·0
SD 0·3 0·3 0·3 0·3 0·3
Sex, male 99 44·2 137 49·3 121 50·2 132 51·6 104 42·3
Low birth weight, ,2·5 kg† 29 13·2 36 13·1 34 14·2 35 14·0 30 12·4
Stunted at 6 months‡ 33 14·8 28 10·1 30 12·5 34 13·3 27 11·0
Breast feeding
Never breastfed 40 17·9 2 0·7 1 0·4 22 8·6 20 8·1
, 6 months 52 23·2 10 3·6 6 2·5 34 13·3 28 11·4
$ 6 months 132 58·9 265 95·7 235 97·1 200 78·1 198 80·5
Anaemia, Hb , 105 g/l§ 91 41·5 105 38·0 93 39·6 94 36·9 102 42·5
Mothers’ characteristics
Age (years)
Mean 27·7 25·4 25·7 26·4 26·5
SD 5·6 5·7 5·7 5·5 5·9
HIV status
Negative – – – – – – 144 56·3 134 54·5
Positive – – – – – – 79 31·1 78 31·6
Unknown – – – – – – 33 13·0 34 13·8
Education
None/primary 87 38·8 91 32·7 74 30·7 80 31·2 98 39·8
Secondary 88 39·3 102 36·7 95 39·0 112 43·8 78 31·7
College/university 49 21·9 85 30·6 73 30·3 64 25·0 70 28·5
Marital status
Married 169 75·5 205 73·7 183 75·9 191 74·6 183 74·4
Single or never married 41 18·3 59 21·2 51 21·2 54 21·1 46 18·7
Widowed/divorced 14 6·2 14 5·1 7 2·9 11 4·3 17 6·9
Socio-economic status
Low 84 37·5 87 31·3 79 32·8 84 32·8 87 35·4
Middle 83 37·1 108 38·8 96 39·8 107 41·8 84 34·1
High 57 25·4 83 29·9 66 27·4 65 25·4 75 30·5
Language English 94 42·7 110 54·7 –k 102 47·7 102 49·3
* All planned to have Bayley testing.
† Information was missing for eleven children.
‡ Length for age , 22 Z; not available for one child.
§ Information was missing for thirteen children.
kData not collected for children not assigned to Bayley testing.
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Table 4. Univariable association between mental development index (MDI) and psychomotor development index (PDI) scores at 6 and 18 months and characteristics of the infants and their mothers
(Mean values and standard deviations)
6 months 18 months
Subjects (n 420) MDI score PDI score Subjects (n 335) MDI score PDI score
n % Mean SD P Mean SD P n % Mean SD P * Mean SD P *
Infants’ characteristics
Sex
Male 199 47·4 99·2 7·0 102·1 10·0 159 47·5 88·4 7·9 90·5 6·5
Female 221 52·6 99·0 6·9 0·83 102·3 9·3 0·82 176 52·5 89·6 6·8 0·19 90·9 5·8 0·39
Birth weight†
,2·5 kg 54 13·1 95·3 10·6 96·9 14·4 45 13·6 87·2 7·4 88·3 6·0
$ 2·5 kg 358 86·9 99·7 6·0 ,0·01 103·1 8·3 ,0·01 287 86·4 89·3 7·4 0·09 91·1 6·1 ,0·01
Stunting at the assessment‡
Yes 55 13·1 95·7 9·3 97·2 13·6 77 23·1 86·0 7·6 87·3 8·0
No 364 86·9 99·6 6·4 ,0·01 103·0 8·5 ,0·01 257 76·9 89·9 7·1 ,0·01 91·7 5·1 ,0·01
Anaemia at the assessment§
Yes 163 39·4 98·1 7·1 101·4 10·1 104 31·3 87·9 6·7 90·0 6·0
No 251 60·6 99·8 6·8 0·01 102·7 9·2 0·20 228 68·7 89·5 7·6 0·11 90·9 6·2 0·07
HIV status at 18 monthsk
Negative 319 96·1 89·1 7·4 90·8 6·2
Positive 13 3·9 87·3 9·0 0·37 88·5 6·5 0·20
Mothers’ characteristics
HIV status{
Negative 201 47·9 99·3 6·4 102·4 9·1 155 46·3 89·4 6·8 91·4 5·5
Positive 156 37·1 98·9 7·4 101·9 10·1 133 39·7 87·9 7·6 89·6 7·1
Unknown 63 15·0 98·7 7·5 0·78 102·1 10·0 0·85 47 14·0 91·0 8·2 0·03 91·6 4·8 0·03
Education
None/primary 149 35·5 98·8 7·4 102·3 10·6 112 33·4 88·9 7·3 89·2 7·1
Secondary 164 39·0 99·3 6·7 102·7 8·9 134 40·0 88·5 7·5 91·2 5·8
College/university 107 25·5 99·1 6·6 0·78 101·2 9·3 0·47 89 26·6 89·8 7·5 0·51 91·8 5·1 0·02
Socio-economic status
Low 152 36·2 98·8 7·7 102·9 10·7 117 34·9 88·5 6·6 89·6 6·2
Middle 158 37·6 99·2 6·4 101·4 9·0 128 38·2 89·0 8·1 91·0 6·5
High 110 26·2 99·3 6·5 0·76 102·2 8·8 0·38 90 26·9 89·6 7·2 0·53 91·7 5·5 0·05
Language
English 203 48·3 99·2 6·2 102·1 8·8 164 49·0 89·0 7·4 91·7 5·0
Other languages** 217 51·7 99·0 7·7 0·69 102·2 10·3 0·90 171 51·0 89·0 7·5 0·92 89·7 7·0 ,0·01
*P value at 18 months obtained by linear regression adjusting for treatment arm.
† Information was missing for eight infants.
‡ Length for age,22 Z; not available for one infant.
§ Hb , 105 g/l; information was missing for seven infants at 6 months and three infants at 18 months.
kNot available for three infants.
{Reported or from clinical records.
** Bemba or Nyanja.
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The present results concur with findings from studies in
Nepal(9), India(10) and Indonesia(11) that found no significant
benefit(9,10) or a hint of disadvantage(11) to scores on BSID
II. By contrast the present results do not concur with findings
from four other studies that found benefits to motor mile-
stones or motor development on the Bayley scales(5–8). In
Zanzibar, benefits were found to the age of walking in infants
after 1-year supplementation with Fe, Zn and folate(8). The
effect of intervention was stronger in anaemic children and
they had a higher prevalence of anaemia at baseline (63 %
with a cut-off of 100 g/l)(8) compared with infants in the
CIGNIS (approximately 40 % with a cut-off of 105 g/l). How-
ever, in the present study, the effect of the intervention was
not more beneficial in children anaemic at baseline. In
Ghana a positive effect was found on walking at 12 months
in the two groups receiving different amounts of micro-
nutrients and one group receiving micronutrients and energy
compared with a non-intervention control group(5). However,
in that study the control group was not randomised as part of
the trial and may not have received the same level of care as
the study participants.
The present study has several strengths. It is one of the few
randomised controlled trials investigating the effect of multiple
micronutrient fortification alone (the two trial porridges had
equal amount of energy) on mental and motor development
in children under the age of 5 years(4,9) and it was powered
to detect clinically significant differences. It was conducted
in an area of documented micronutrient malnutrition(12,13)
and we had evidence of good compliance(15). The develop-
ment assessment was comprehensive and the Bayley test
showed good reliability and appeared valid in this population.
The study also has some limitations that should be con-
sidered when interpreting the results. Bayley assessment was
performed in a subsample of the CIGNIS trial, which included
all infants of HIV-positive or HIV-unknown mothers and every
other child of HIV-negative women. The latter criterion was
chosen to spread the testing over the entire study period,
thus maintaining a steady workload and the random allocation
of intervention. As planned, there was a higher proportion of
infants of HIV-positive mothers in the subsample compared
with the general population attending the Chilenje clinic.
However, there was no evidence that the effect of the inter-
vention on Bayley scores was modified by maternal HIV
status; therefore the present results should be applicable to
the general population of Chilenje.
Loss from the study could have biased the results. A number
of infants assigned to the Bayley test (16 %) were not tested
(mainly because mothers refused) and we had approximately
20 % lost to follow up. Mothers not participating in Bayley test-
ing were more frequently HIV negative, but their infants were
otherwise very similar to the Bayley test participants (also in
term of growth and milestones achieved) and equally
balanced between trial arms. Infants of younger and HIV-
negative mothers were more likely to be lost to follow up
but were equally balanced between trial arms and their
developmental scores at baseline and before withdrawal
were similar to those children who completed the follow up.
In the analysis, we accounted for losses to follow up, fitting
a multilevel mixed-effect model, which has the advantage of
implicitly predicting missing values using the overall pattern
of the existing data, based on the missing at random assump-
tion(23). In the present study, being lost to follow up was
influenced by maternal age and HIV status but was unrelated
to the intervention and to outcome measurements before
withdrawals, therefore was plausibly at random(23).
As an additional approach to account for both infants not
participating in Bayley testing and infants lost to follow up,
we imputed missing data using multiple imputations (with
ten imputing sets). All the known covariates including those
associated with the missingness mechanism (time since enrol-
ment, maternal age and HIV status) and with the outcome
measures (growth data) were included in the imputation pro-
cedures(23). The results of the analysis with multiple imputa-
tions showed no difference between trial arms in term of
Bayley scores and milestones achieved (data not shown).
In conclusion, the present study suggests that 1 year of rich
multiple micronutrient fortification does not have any benefit
on child development compared with basal fortification. The
latter coupled with adequate energy intake remains important
for Zambian infants and resources should be used to
implement this intervention.
Table 5. Mental development index (MDI) and psychomotor development index (PDI) scores at 6, 12 and 18 months
(Mean values and standard deviations and differences and 95 % confidence intervals)
Basal fortified
porridge (n 256)
Richly fortified
porridge (n 246) Unadjusted* Adjusted*†
Mean SD Mean SD Difference 95 % CI P Difference 95 % CI P
6 months (n 420)
MDI score 99·0 6·4 99·2 7·5 0·1 21·2, 1·5 0·84 – – –
PDI score 102·0 9·0 102·3 10·3 0·3 21·6, 2·1 0·76 – – –
12 months (n 364)
MDI score 95·1 7·9 95·9 8·7 0·8 20·9, 2·6 0·33 0·8 20·8, 2·4 0·34
PDI score 93·1 9·2 93·4 10·4 0·3 21·7, 2·3 0·78 0·3 21·5, 2·1 0·70
18 months (n 335)
MDI score 88·4 7·4 89·8 7·4 1·4 20·2, 3·0 0·09 1·3 20·3, 2·8 0·11
PDI score 91·4 6·1 90·0 6·2 21·4 22·8, 20·1 0·03 21·6 22·8, 20·3 0·02
* Basal fortified porridge used as the baseline category.
† Adjusted for baseline score, age at the assessment, sex, socio-economic status, maternal education and language (English v. other languages).
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